ENCBS387ENC / cell line
Summary
- Status
- released
- Term name
- LNCaP clone FGC
- Term ID
- EFO:0005726
- Summary
- Homo sapiens LNCaP clone FGC cell line treated with 1 nM 17β-hydroxy-17-methylestra-4,9,11-trien-3-one for 12 hours
- Description
- prostate adenocarcinoma, LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old caucasian male (blood type B+) with confirmed diagnosis of metastatic prostate carcinoma. - ATCC. (Horoszewicz et al. LNCaP Model of Human Prostatic Carcinoma. Cancer Research 43, 1809-1818, April 1983.)
- Product ID
- CRL-1740
Attribution
ENCODE2 project
- Lab
- Gregory Crawford, Duke
- Award PI
- Gregory Crawford, Duke
- Submitted by
- Terry Furey
- Source
- ATCC
- Project
- ENCODE
- External resources
Treatment details
- Treatment
- 1 nM 17β-hydroxy-17-methylestra-4,9,11-trien-3-one (CHEBI:379896) for 12 hours
- Type
- chemical
Donor information
- Status
- released
- Accession
- ENCDO000ACX
- Aliases
- encode:donor of C4-2B, encode:donor of LNCaP clone FGC, encode:donor of LNCAP
- Species
- Homo sapiens
- Life stage
- adult
- Age
- 50 years
- Sex
- male
- Health status
- prostate adenocarcinoma
- Ethnicity
- European
- External resources
- References
Documents
growth protocol
Description: LNCaP cell line (ATCC #CRL‐1740) culture conditions +/- androgen treatment
- Submitted by
- Gregory Crawford
- Lab
- Gregory Crawford, Duke
- Grant
- U54HG004563